CUV 14.6% $17.38 clinuvel pharmaceuticals limited

And the CUV052 study commenced after additional data was...

  1. 877 Posts.
    lightbulb Created with Sketch. 236
    And the CUV052 study commenced after additional data was requested is not yet completed, due to be completed and results released sometime in 2024. FWIW it may be more a technical matter in dealing with European approval whereby simply a new application is required in conjunction with the CUV052 study and a nothing burger, with the process simply run-out in terms of the now defunct application.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.